Dark Forest Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Dark Forest Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,843	Closed	-$37K	–	1905
2021 Q3	$37K	Buy	1,843 +1,610	+691%	+$44.4K	0.01%	649
2021 Q2	$9K	Buy	+233	New	+$7.14K	﹤0.01%	653

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Dark Forest Capital Management's DRNA Position: Q4 2021 in Review

Dark Forest Capital Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 1,843 shares — an estimated $37K sold.

Dark Forest Capital Management first reported a position in DRNA in Q2 2021 and held it in 2 quarters. The position peaked at $37K in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Dark Forest Capital Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Dark Forest Capital Management sold 1,843 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $37K.
Dark Forest Capital Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
Dark Forest Capital Management's Dicerna Pharmaceuticals, Inc. position peaked at $37K in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Dark Forest Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.